Dr. Kumar Rishikesh
Oncologist · Indraprastha Apollo Hospital
Indraprastha Apollo Hospital, Delhi• View Hospital★ Malignant-melanoma16+ Yrs. Experience
MBBSMD (General Medicine)DNB (Medical Oncology)
Quick Facts
- Department
- Malignant-melanoma
- Qualifications
- MBBS, MD (General Medicine), DNB (Medical Oncology)
- Experience
- 16+ Years
- Hospital
- Indraprastha Apollo Hospital
- Location
- Delhi NCR, India
- International Support
- Visa Assistance & Interpreters
About Dr. Kumar Rishikesh
Dr. Kumar Rishikesh is a skilled Medical Oncologist at Apollo Hospitals Indraprastha, New Delhi. Dr. Kumar has 15 years of experience and advanced degrees in medicine and oncology. He completed a fellowship at the University of Toronto's Princess Margaret Cancer Centre. Dr. Rishikesh treats a wide range of cancers and related conditions. He's known for his personalized approach to patient care. His research experience includes participating in clinical trials in Toronto. Dr. Rishikesh aims to develop cancer treatments tailored to Indian patients. He's passionate about making India self-reliant in cancer research and treatment. Consult Dr. Kumar Rishikesh with Marlin Medical Assistance for expert Medical Oncology care. Personalized treatment for comprehensive cancer management and support .
Education & Qualifications
MBBS
MD (General Medicine)
DNB (Medical Oncology)
Clinical Career Timeline
Indraprastha Hospital, New Delhi, Consultant - Medical Oncology
Accreditations & Professional Memberships
Winner of the Best Clinical Investigator award.
Languages Spoken
EnglishHindi🌐 Multilingual Interpreter Support Available (Arabic, Russian, French)
Treatments Performed
★
Core Speciality
Malignant-melanoma
★
Core Speciality
Langerhans Cell Histiocytosis
★
Core Speciality
Renal Cell Carcinoma
★
Core Speciality
Acute Lymphoblastic Leukemia
★
Core Speciality
Hairy cell leukemia
★
Core Speciality
Cholangiocarcinoma
★
Core Speciality
Amyotrophic lateral sclerosis
★
Core Speciality
Actinic keratosis
★
Core Speciality
Ovarian Tumors
Interventional & Quaternary Procedures5 Procedures
ChemotherapyTargeted therapyImmunotherapyLumber PuncturePleurodesis
Advanced Diagnostics & Specialized Surgeries5 Procedures
PICC line / HickmanIntrathecal ChemotherapyCentral line insertionBone Marrow Aspiration and BiopsyIntraarterial Chemotherapy IAC for retinoblastomas
Practices At
Indraprastha Apollo Hospital, Delhi
Indraprastha Apollo Hospitals, Sarita Vihar, Delhi Mathura Road New Delhi 110076 India
JCI AccreditedNABH CertifiedMarlin Verified Partner
Explore hospital facilities & doctors
What to Expect: Medical Oncology
Comparative Benchmarks · India vs US / UKSave 70% – 85% in India
| Procedure | US / UK Estimate | India Package Price | Savings |
|---|---|---|---|
| Targeted Immunotherapy & Chemotherapy Protocol | $45,000 US/UK | $4,800 – $8,500 in India | 82% Less |
| Robotic Tumor Resection Surgery | $55,000 US/UK | $6,500 – $9,200 in India | 84% Less |
| CyberKnife Stereotactic Radiation Therapy | $42,000 US/UK | $5,500 – $7,500 in India | 83% Less |
Medical Advisory: Illustrative cost benchmarks include surgeon fees, standard implants/lenses, operation theatre charges, nursing, and standard hospital stay. Final quotes are confirmed by the hospital medical board after reviewing personal clinical scans.
Reviews
Amara Okafor
“Dr. Kumar Rishikesh provided an exhaustive clinical consultation. Marlin coordinated all pre-travel scans and hospital admission seamlessly.”
Kareem Al-Mansoor
“Exceptional surgical skill and world-class post-operative care at Indraprastha Apollo Hospital. Highly recommended for international patients.”
Similar Medical Oncology Specialists
Frequently Asked Questions
What is Dr. Kumar Rishikesh’s area of specialization?
He specializes in Medical Oncology and Hematology.
How many years of experience does Dr. Kumar Rishikesh have?
Dr. Rishikesh has 15 years of experience.
What types of conditions does Dr. Kumar Rishikesh treat?
He treats a wide range of conditions including Actinic Keratosis, ALS, Cholangiocarcinoma, Hairy Cell Leukemia, Ovarian Cysts, Acute Lymphoblastic Leukemia, Renal Cell Carcinoma, and Gastric Cancer.